Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Major Depressive Episodes in Psychotic Disorders
NCT00224302Phase 4Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Aug 2005
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of duloxetine in major depressive disorder (MDD), sponsored by Central Institute of Mental Health. Started Aug 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00224302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00224302.